electroCore, Inc. (ECOR)
NASDAQ · Manufacturing · Electromedical & electrotherapeutic apparatus
$11.12−$0.2300 (−2.03%) on the dayAs of the close; data may be delayed.
ECOR price, last 12 months
Key stats
- Previous close
- $11.35
- Open
- $11.34
- Day range
- $11.00 – $11.47
- 52-week range
- $4.41 – $12.70
- Volume
- 52.2K
- Avg volume (20 days)
- 86.6K
- Market cap
- $100.3M
Performance
1W−4.8%
1M+7.4%
3M+41.8%
6M+84.7%
YTD+147.9%
1Y+115.9%
vs S&P 500, 1Y+99.1 pts
Technicals and fundamentals
About electroCore, Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
- Sector
- Manufacturing
- Industry
- Electromedical & electrotherapeutic apparatus
- Listed on
- NASDAQ
- Market cap
- $100.3M